Literature DB >> 7824065

Evidence of an oxidative challenge in the Alzheimer's brain.

L Balazs1, M Leon.   

Abstract

Alzheimer's disease may arise from or produce oxidative damage in the brain. To assess the responses of the Alzheimer's brain to possible oxidative challenges, we assayed for glutathione, glucose-6-phosphate dehydrogenase, catalase and superoxide dismutase in twelve regions of Alzheimer's disease and aged control brains. In addition, we determined levels of malondialdehyde to evaluate lipid peroxidation in these brain regions. Most brain regions showed evidence of a response to an oxidative challenge, but the cellular response to this challenge differed among brain regions. These data suggest that the entire Alzheimer's brain may be subject to an oxidative challenge, but that some brain areas may be more vulnerable than others to the consequent neural damage that characterizes the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824065     DOI: 10.1007/bf00965146

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study.

Authors:  R Perrin; S Briançon; C Jeandel; Y Artur; A Minn; F Penin; G Siest
Journal:  Gerontology       Date:  1990       Impact factor: 5.140

2.  Effect of long-term feeding of aluminium chloride on hexokinase and glucose-6-phosphate dehydrogenase in the brain.

Authors:  S Cho; J G Joshi
Journal:  Toxicology       Date:  1988-01       Impact factor: 4.221

3.  Measurement of catalase activity in tissue extracts.

Authors:  G Cohen; D Dembiec; J Marcus
Journal:  Anal Biochem       Date:  1970-03       Impact factor: 3.365

4.  A simple specific method for the determination of the hemoglobin content of tissue homogenates.

Authors:  S Marklund
Journal:  Clin Chim Acta       Date:  1979-03-01       Impact factor: 3.786

5.  Free radical theory of aging: inhibition of amyloidosis in mice by antioxidants; possible mechanism.

Authors:  D Harman; D E Eddy; J Noffsinger
Journal:  J Am Geriatr Soc       Date:  1976-05       Impact factor: 5.562

6.  Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro.

Authors:  K V Subbarao; J S Richardson; L C Ang
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

7.  In vivo formation of single-strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction.

Authors:  A C Mello Filho; R Meneghini
Journal:  Biochim Biophys Acta       Date:  1984-02-24

8.  Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

Authors:  J D Adams; L K Klaidman; I N Odunze; H C Shen; C A Miller
Journal:  Mol Chem Neuropathol       Date:  1991-06

9.  Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type.

Authors:  S L Marklund; R Adolfsson; C G Gottfries; B Winblad
Journal:  J Neurol Sci       Date:  1985-03       Impact factor: 3.181

10.  Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease.

Authors:  T L Perry; V W Yong; C Bergeron; S Hansen; K Jones
Journal:  Ann Neurol       Date:  1987-04       Impact factor: 10.422

View more
  33 in total

1.  Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress.

Authors:  P Lagrange; R D El-Bachá; P Netter; A Minn
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

Review 2.  Exercise attenuates the major hallmarks of aging.

Authors:  Nuria Garatachea; Helios Pareja-Galeano; Fabian Sanchis-Gomar; Alejandro Santos-Lozano; Carmen Fiuza-Luces; María Morán; Enzo Emanuele; Michael J Joyner; Alejandro Lucia
Journal:  Rejuvenation Res       Date:  2015-02       Impact factor: 4.663

3.  Regional membrane phospholipid alterations in Alzheimer's disease.

Authors:  M R Prasad; M A Lovell; M Yatin; H Dhillon; W R Markesbery
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

4.  Alzheimer's Abeta1-40 peptide modulates lipid synthesis in neuronal cultures and intact rat fetal brain under normoxic and oxidative stress conditions.

Authors:  N V Koudinova; A R Koudinov; E Yavin
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

5.  The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.

Authors:  S M Yatin; M Aksenov; D A Butterfield
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

6.  The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

7.  Calcium-activated NO production plays a role in neuronal death induced by beta-bungarotoxin in primary cultures of cerebellar granular neurons.

Authors:  Wen-Pei Tseng; Shoei-Yn Lin-Shiau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-17       Impact factor: 3.000

8.  Development of multiple QSAR models for consensus predictions and unified mechanistic interpretations of the free-radical scavenging activities of chromone derivatives.

Authors:  Indrani Mitra; Achintya Saha; Kunal Roy
Journal:  J Mol Model       Date:  2011-08-18       Impact factor: 1.810

Review 9.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

10.  Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

Authors:  Mubeen A Ansari; Stephen W Scheff
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.